Galip Can Uyar
Galip Can Uyar/LinkedIn

Galip Can Uyar: The Prognostic Value of LRF and Inflammatory Biomarkers in SCLC

Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared a post on X about a paper he co-authored with colleagues, published in Clinical and Translational Oncology:

“Excited to share our new article in Clinical and Translational Oncology!

We highlight the prognostic value of PET/CT-derived liver-to-muscle FDG uptake ratio (LRF) and inflammatory biomarkers in small-cell lung cancer.

Elevated LRF reflects metabolic frailty and predicts poor outcomes.”

Title: Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer

Authors: Kadriye Başkurt, Semra Demirtaş Şenlik, Galip Can Uyar, Enes Yeşilbaş, Ömür Berna Çakmak Öksüzoğlu, Osman Sütcüoğlu

You can read the Full Article in Clinical and Translational Oncology.

Galip Can Uyar: The Prognostic Value of LRF and Inflammatory Biomarkers in SCLC

You can also read the first author’s post on OncoDaily.

Liver-to-Muscle FDG

More posts featuring Galip Can Uyar.